Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 8,190 shares at $180.12 ($1.5M) on 2021-05-11, disclosed to the SEC on 2021-05-12.
Open-market sale of $1.5M NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.65 | 1,833 | $348K | 23.0% |
| 2 | $189.65 | 1,833 | $348K | 23.0% |
| 3 | $180.12 | 2,262 | $407K | 27.0% |
| 4 | $180.12 | 2,262 | $407K | 27.0% |
| Total | $184.39 avg | 8,190 | $1.5M | 100% |
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |